Farms.com Home   News

Dairy Supply Chain Takes A Hit

The dairy sector is another industry feeling the impacts of the shutdowns associated with COVID 19.

Like many other commodities, COVID 19, has created fluctuations in the dairy market.

Dairy Farmers of Canada says the virtual shutdown of the restaurant industry and changing grocery shopping patterns have had a significant impact on the demand for key dairy products.

The supply versus demand story is hitting the dairy sector hard as producers dispose of raw milk due to the lack of demand.

Stats show that there are 516 dairy farms in Alberta and 165 in Saskatchewan.

The situation is not unique to Canada as other countries around the world face similar stories including the U-S.

In order to keep dairy cows comfortable and healthy, they must be milked on a regular basis, as each animal produces a certain amount of milk each day.

Dairy farmers and processors are committed to producing a safe consistent supply and are donating significant volumes of dairy products to food banks where they can, but the volume of supply compared to the demand is an issue.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.